|
| 35361262 | Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas. | Acta Neuropathol Commun | 2022 |
| 35831316 | The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors. | Nat Commun | 2022 |
| 34503197 | The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2021 |
| 33631540 | Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link? | Eur J Cancer | 2021 |
| 34584066 | The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma. | Cell Death Dis | 2021 |
| 34628166 | Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses. | Biomed Pharmacother | 2021 |
| 30548945 | MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy. | Neuropathol Appl Neurobiol | 2019 |
| 26919320 | Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel. | Brain Pathol | 2017 |
| 26223576 | Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas. | Brain Pathol | 2016 |
| 26887050 | MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. | Oncotarget | 2016 |
| 26919435 | New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. | Cell | 2016 |
| 24305703 | MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. | Neuro Oncol | 2014 |
| 25277195 | MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape. | Oncotarget | 2014 |
| 22158042 | Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro. | Oncogene | 2012 |
| 23079654 | Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. | Cancer Cell | 2012 |
| 20473936 | Molecular signatures classify astrocytic gliomas by IDH1 mutation status. | Int J Cancer | 2011 |
| 21939466 | Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets. | Brain Pathol | 2011 |
| 19775293 | Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. | Brain Pathol | 2010 |
| 20131059 | Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing. | Acta Neuropathol | 2010 |
| 20124482 | Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. | Cancer Res | 2010 |
| 20167812 | Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q. | Neuro Oncol | 2010 |
| 20305691 | De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. | Oncogene | 2010 |
| 20375133 | A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. | Brain | 2010 |
| 19922547 | Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. | Brain Pathol | 2010 |
| 19847810 | Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. | Int J Cancer | 2010 |
| 19554337 | Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. | Acta Neuropathol | 2009 |
| 20017917 | ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. | BMC Cancer | 2009 |
| 18709645 | Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. | Int J Cancer | 2008 |
| 17610521 | DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas. | Brain Pathol | 2007 |
| 16400626 | Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. | J Pathol | 2006 |
| 16865689 | Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. | Int J Cancer | 2006 |
| 15455350 | Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. | Int J Cancer | 2005 |
| 15521068 | Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. | J Cell Physiol | 2005 |
| 15656799 | Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. | Br J Dermatol | 2005 |
| 15688172 | [Silica-containing urinary stones--clinical issues to keep in mind]. | Urologe A | 2005 |
| 15239147 | Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas. | Int J Cancer | 2004 |
| 12937144 | Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. | Am J Pathol | 2003 |
| 12898158 | Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas. | Acta Neuropathol | 2003 |
| 12124804 | Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. | Int J Cancer | 2002 |
| 12112531 | Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. | Genes Chromosomes Cancer | 2002 |
| 12109857 | Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions. | Am J Clin Pathol | 2002 |
| 11433413 | Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. | Int J Cancer | 2001 |
| 11355302 | Molecular genetic alterations in glioblastomas with oligodendroglial component. | Acta Neuropathol | 2001 |
| 11304690 | Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18. | Int J Cancer | 2001 |
| 11764089 | Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. | J Neuropathol Exp Neurol | 2001 |
| 11485924 | Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. | Am J Pathol | 2001 |
| 11392879 | Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus. | Am J Clin Pathol | 2001 |
| 10881743 | Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. | Virchows Arch | 2000 |
| 10514383 | Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus. | Am J Pathol | 1999 |
| 10469459 | Genomic imbalances are rare in hairy cell leukemia. | Genes Chromosomes Cancer | 1999 |